Long-term follow-up of spinal and bulbar muscular atrophy in Taiwan

被引:14
|
作者
Fu, Ser-Chen [1 ,2 ,3 ]
Kuo, Hung-Chou [1 ,2 ]
Chu, Chun-Che [1 ,2 ]
Wu, Yih-Ru [1 ,2 ]
Ro, Long-Sun [1 ,2 ]
Liu, Chin-San [3 ]
Huang, Chin-Chang [4 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Neurol, Taipei, Taiwan
[2] Chang Gung Univ, Taipei, Taiwan
[3] Buddhist Tzu Chi Gen Hosp, Dept Neurol, Taipei, Taiwan
[4] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan
关键词
Kennedy disease; spinal and bulbar muscular atrophy; Taiwan; X-linked recessive bulbospinal muscular atrophy; RECESSIVE BULBOSPINAL NEURONOPATHY; ANDROGEN-RECEPTOR GENE; KENNEDY-DISEASE; NATURAL-HISTORY; CAG-REPEAT; FEATURES; FAMILY; SBMA; NEUROPATHY; EXPANSION;
D O I
10.1016/j.jfma.2012.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Purpose: Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy disease, is a rare neurodegenerative disorder presenting with insidious onset of weakness in bulbar and limb muscles. Information regarding long-term clinical and functional progression has been limited, especially for the Taiwanese population. The purpose of the study aimed to investigate early diagnosis and long-term prognosis of SBMA. Methods: We retrospectively analyzed 21 genetically confirmed SBMA patients who visited our hospital between 1993 and 2010, focusing on clinical symptoms, nerve conduction studies, and functional disability. We also analyzed the relationship between length of cytosine-adenine-guanine (CAG) repeats and age of disease onset. Results: Weakness developed at a mean age of 39 +/- 7 years (mean +/- standard deviation). The length of CAG repeats and age at onset of weakness showed inverse (but nonsignificant) correlation. The most common symptoms at initial presentation were hand tremor (86%), limb weakness (86%), and perioral fasciculation (76%). Creatine kinase (CK) was elevated in 17 out of 18 patients. Initial nerve conduction studies showed statistical difference from normal controls, especially decreased amplitudes of compound motor action potential (CMAP) and sensory nerve action potential (SNAP). Functional disability showed very slow progression, with only three patients becoming wheelchair-dependent during follow-up at a median age of 72 years. Conclusion: Patients with SBMA may present with a myriad of symptoms, including limbs weakness, tremor, muscle atrophy, and perioral fasciculations. Elevated serum CK and decreased CMAP and SNAP amplitudes were supportive laboratory findings of SBMA. Disease progression was gradual, and most patients remained functionally independent many years after the onset of weakness. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
引用
收藏
页码:326 / 331
页数:6
相关论文
共 50 条
  • [31] Progress toward the development of treatment of spinal and bulbar muscular atrophy
    Sahashi, Kentaro
    Hashizume, Atsushi
    Sobue, Gen
    Katsuno, Masahisa
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 503 - 514
  • [32] Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and Future
    Weydt, Patrick
    Sagnelli, Anna
    Rosenbohm, Angela
    Fratta, Pietro
    Pradat, Pierre-Francois
    Ludolph, Albert C.
    Pareyson, Davide
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 379 - 387
  • [33] Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia
    Lund, A
    Udd, B
    Juvonen, V
    Andersen, PM
    Cederquist, K
    Ronnevi, LO
    Sistonen, P
    Sörensen, SA
    Tranebjærg, L
    Wallgren-Pettersson, C
    Savontaus, ML
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (08) : 631 - 636
  • [34] Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy
    Adachi, H.
    Waza, M.
    Katsuno, M.
    Tanaka, F.
    Doyu, M.
    Sobue, G.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (02) : 135 - 151
  • [35] Spinal and Bulbar Muscular Atrophy Overview
    Kenneth H. Fischbeck
    Journal of Molecular Neuroscience, 2016, 58 : 317 - 320
  • [36] Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
    Katsuno, Masahisa
    Tanaka, Fumiaki
    Adachi, Hiroaki
    Banno, Haruhiko
    Suzuki, Keisuke
    Watanabe, Hirohisa
    Sobue, Gen
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 246 - 256
  • [37] Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients
    Atsuta, Naoki
    Watanabe, Hirohisa
    Ito, Mizuki
    Banno, Haruhiko
    Suzuki, Keisuke
    Katsuno, Masahisa
    Tanaka, Fumiaki
    Tamakoshi, Akiko
    Sobue, Gen
    BRAIN, 2006, 129 : 1446 - 1455
  • [38] Neurotoxic effects of androgens in spinal and bulbar muscular atrophy
    Parodi, Sara
    Pennuto, Maria
    FRONTIERS IN NEUROENDOCRINOLOGY, 2011, 32 (04) : 416 - 425
  • [39] Clinical Trials in Spinal and Bulbar Muscular Atrophy—Past, Present, and Future
    Patrick Weydt
    Anna Sagnelli
    Angela Rosenbohm
    Pietro Fratta
    Pierre-François Pradat
    Albert C. Ludolph
    Davide Pareyson
    Journal of Molecular Neuroscience, 2016, 58 : 379 - 387
  • [40] Reliability and Validity of the Korean Version of the Spinal and Bulbar Muscular Atrophy Functional Rating Scale
    Oh, Seong-il
    Oh, Juyeon
    Park, Donghwi
    Son, Kwangjoo
    Park, Jin-Sung
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (04): : 586 - 591